FOXP3 and breast carcinoma: In contrast to HR+ breast cancer, FOXP3 TILs strongly correlate with a favorable prognosis in HR− and TNBC subtypes (Jiang et al. 2015, Mahmoud et al. 2011, Tsang et al. 2014, West et al. 2013).